Here, we observed that CTC1 expression was negatively associated with miR-376a-3p in adrenocortical carcinoma patients and that the overall survival is dramatically decreased with low CTC1 levels, suggesting that miR-376a-3p may stimulate adrenocortical carcinoma by targeting CTC1. Here, CTC1 is linked to adrenal cortex carcinoma.